Literature DB >> 22238406

Symptomatic heterozygotes and prenatal diagnoses in a nonconsanguineous family with syndromic combined pituitary hormone deficiency resulting from two novel LHX3 mutations.

Marie-Laure Sobrier1, Cécile Brachet, Marie-Pierre Vié-Luton, Christelle Perez, Bruno Copin, Marie Legendre, Claudine Heinrichs, Serge Amselem.   

Abstract

CONTEXT: Only 11 mutations have been reported in the transcription factor LHX3, known to be important for the development of the pituitary and motor neurons. All patients were homozygous, with various syndromic forms of combined pituitary hormone deficiency (CPHD), hampering to allocate, in these consanguineous patients, the respective contribution of LHX3 and additional genes to each symptom.
OBJECTIVE: The aim of the study was to report the family history and the molecular basis of a nonconsanguineous patient with syndromic CPHD. PATIENT: The patient, who presented at birth with respiratory distress, had a syndromic CPHD, including severe scoliosis, and normal intelligence. His father and paternal grandmother displayed limited head rotation.
RESULTS: Two new LHX3 defects were identified. The paternally inherited c.252-3C>G mutation, which disrupts an acceptor splice site, would lead to severely truncated proteins containing a single LIM domain, resembling LIM-only proteins. Coexpression studies revealed the dominant-negative effect of this LIM-only protein over the wild-type LHX3. The maternally inherited p.Cys118Tyr mutation results in partial loss of transcriptional activity and synergy with POU1F1. Given the severity of the patient's phenotype, two prenatal diagnoses were performed: the first led to pregnancy interruption, the second to the birth of a healthy boy.
CONCLUSIONS: This study of the first nonconsanguineous patient with LHX3 mutations demonstrates the pleiotropic roles of LHX3 during development and its full involvement in the complex disease phenotype. Isolated limitation of head rotation may exist in heterozygous carriers and would result from a dominant-negative effect. These data allowed the first prenatal diagnoses of this severe condition to be performed.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22238406     DOI: 10.1210/jc.2011-2095

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  9 in total

1.  Heterozygous LHX3 mutations may lead to a mild phenotype of combined pituitary hormone deficiency.

Authors:  Nicolas Jullien; Pauline Romanet; Mélanie Philippon; Marie-Hélène Quentien; Paolo Beck-Peccoz; Ignacio Bergada; Sylvie Odent; Rachel Reynaud; Anne Barlier; Alexandru Saveanu; Thierry Brue; Frederic Castinetti
Journal:  Eur J Hum Genet       Date:  2018-09-27       Impact factor: 4.246

2.  Functional characterization of a human POU1F1 mutation associated with isolated growth hormone deficiency: a novel etiology for IGHD.

Authors:  Marie-Laure Sobrier; Yu-Cheng Tsai; Christelle Pérez; Bruno Leheup; Tahar Bouceba; Philippe Duquesnoy; Bruno Copin; Daria Sizova; Alfredo Penzo; Ben Z Stanger; Nancy E Cooke; Stephen A Liebhaber; Serge Amselem
Journal:  Hum Mol Genet       Date:  2015-11-26       Impact factor: 6.150

3.  Developmental analysis and influence of genetic background on the Lhx3 W227ter mouse model of combined pituitary hormone deficiency disease.

Authors:  Kelly L Prince; Stephanie C Colvin; Soyoung Park; Xianyin Lai; Frank A Witzmann; Simon J Rhodes
Journal:  Endocrinology       Date:  2013-01-03       Impact factor: 4.736

4.  Cell-specific actions of a human LHX3 gene enhancer during pituitary and spinal cord development.

Authors:  Soyoung Park; Rachel D Mullen; Simon J Rhodes
Journal:  Mol Endocrinol       Date:  2013-10-07

5.  Atlanto-axial malformation and instability in dogs with pituitary dwarfism due to an LHX3 mutation.

Authors:  A M W Y Voorbij; B P Meij; L W L van Bruggen; G C M Grinwis; Q E M Stassen; H S Kooistra
Journal:  J Vet Intern Med       Date:  2015-01-14       Impact factor: 3.333

6.  Two novel LHX3 mutations in patients with combined pituitary hormone deficiency including cervical rigidity and sensorineural hearing loss.

Authors:  Khushnooda Ramzan; Bassam Bin-Abbas; Lolwa Al-Jomaa; Rabab Allam; Mohammed Al-Owain; Faiqa Imtiaz
Journal:  BMC Endocr Disord       Date:  2017-03-16       Impact factor: 2.763

Review 7.  Congenital Hypopituitarism During the Neonatal Period: Epidemiology, Pathogenesis, Therapeutic Options, and Outcome.

Authors:  Laura Bosch I Ara; Harshini Katugampola; Mehul T Dattani
Journal:  Front Pediatr       Date:  2021-02-02       Impact factor: 3.418

8.  LHX3 interacts with inhibitor of histone acetyltransferase complex subunits LANP and TAF-1β to modulate pituitary gene regulation.

Authors:  Chad S Hunter; Raleigh E Malik; Frank A Witzmann; Simon J Rhodes
Journal:  PLoS One       Date:  2013-07-04       Impact factor: 3.240

9.  NBPF9 Gene May Be Involved in Congenital Hypopituitarism: A Whole-Genome Study of a Boy with Pituitary Stalk Interruption Syndrome and His Family.

Authors:  Cheng-Zhi Wang; Ling-Ling Guo; Qing-Hua Guo; Yi-Ming Mu
Journal:  Int J Endocrinol       Date:  2020-07-18       Impact factor: 3.257

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.